BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28687105)

  • 1. Acquired C1 Inhibitor Deficiency.
    Otani IM; Banerji A
    Immunol Allergy Clin North Am; 2017 Aug; 37(3):497-511. PubMed ID: 28687105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases].
    Jacquin-Porretaz C; Castelain F; Daguindau E; Seilles E; Nardin C; Aubin F; Pelletier F
    Ann Dermatol Venereol; 2018 Oct; 145(10):598-602. PubMed ID: 29673745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired angioedema in B cell lymphoproliferative disease: A retrospective case series.
    Wonnaparhown A; Stefanovic A; Lugar P; Hostetler HP
    Clin Exp Immunol; 2021 Dec; 206(3):378-383. PubMed ID: 34586637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
    Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
    J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity.
    Wu MA; Castelli R
    Clin Chem Lab Med; 2016 Feb; 54(2):207-14. PubMed ID: 26068904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation.
    Cugno M; Castelli R; Cicardi M
    Autoimmun Rev; 2008 Dec; 8(2):156-9. PubMed ID: 19014872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Where we are with acquired angioedema due to C1 inhibitor deficiency: A systematic literature review.
    Shi Y; Wang C
    Clin Immunol; 2021 Sep; 230():108819. PubMed ID: 34358691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.
    Cicardi M; Zingale LC; Pappalardo E; Folcioni A; Agostoni A
    Medicine (Baltimore); 2003 Jul; 82(4):274-81. PubMed ID: 12861105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
    Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
    Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired angioedema: Autoantibody associations and C1q utility as a diagnostic tool.
    Breitbart SI; Bielory L
    Allergy Asthma Proc; 2010; 31(5):428-34. PubMed ID: 20929611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1-inhibitor deficiency and angioedema.
    Carugati A; Pappalardo E; Zingale LC; Cicardi M
    Mol Immunol; 2001 Aug; 38(2-3):161-73. PubMed ID: 11532278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired Angioedema with C1 Inhibitor Deficiency: Occurrence, Clinical Features, and Management: A Nationwide Retrospective Study in the Czech Republic Patients.
    Sobotkova M; Zachova R; Hakl R; Kuklinek P; Kralickova P; Krcmova I; Hanzlikova J; Vachova M; Bartunkova J
    Int Arch Allergy Immunol; 2021; 182(7):642-649. PubMed ID: 33472202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired Angioedema due to C1 Inhibitor Deficiency Preceding Splenic Marginal Zone Lymphoma: Further Insights from Clinical Practice.
    Ferriani MPL; Trevisan-Neto O; Costa JS; Melo JML; Moreno AS; Dias MM; Garibaldi PMM; Pereira GC; Chahud F; Traina F; Arruda LK
    Int Arch Allergy Immunol; 2020; 181(12):941-946. PubMed ID: 32894844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate.
    Bork K; Staubach-Renz P; Hardt J
    Orphanet J Rare Dis; 2019 Mar; 14(1):65. PubMed ID: 30866985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema.
    Cicardi M; Zanichelli A
    Curr Mol Med; 2010 Jun; 10(4):354-60. PubMed ID: 20455857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired Angioedema due to C1-Inhibitor Deficiency: A Challenging Condition.
    Valle SOR; Alonso MLO; Dortas Junior SD; Goudouris ES; de Carvalho ALRB; Capelo AV; Mansour E; Bernardes AF; Leite LFB; Giavina-Bianchi P; Aun MV; Ferriani MPL; Arruda LK; Grumach AS
    Int Arch Allergy Immunol; 2022; 183(5):572-577. PubMed ID: 35325890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chapter 22: Hereditary and acquired angioedema.
    Georgy MS; Pongracic JA
    Allergy Asthma Proc; 2012; 33 Suppl 1():73-76. PubMed ID: 22794695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
    Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
    Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acquired C1-INH deficiencies with autoantibodies (AAE type II).
    Alsenz J; Loos M
    Behring Inst Mitt; 1989 Jul; (84):165-72. PubMed ID: 2679532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A follow-up survey of patients with acquired angioedema due to C1-inhibitor deficiency.
    Pólai Z; Balla Z; Andrási N; Kőhalmi KV; Temesszentandrási G; Benedek S; Varga L; Farkas H
    J Intern Med; 2021 Apr; 289(4):547-558. PubMed ID: 33215769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.